Please note: We are currently experiencing some performance issues across the site, and some pages may be slow to load. We are working on restoring normal service soon. Importing new articles from Word documents is also currently unavailable. We apologize for any inconvenience.
A 58-year-old woman had gastric cancer treated with nivolumab. Her serum
creatinine (Cr) increased to 5.94 mg/dL post two cycles of nivolumab and
co-administered with acemetacin. A kidney biopsy showed acute tubular
injury (ATI).